This is a preview of subscription content, log in via an institution to check access.
References
Original articles
Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429–434 (2021)
Rothgangl, T. et al. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nat. Biotechnol. https://doi.org/10.1038/s41587-021-00933-4 (2021)
Gennemark, P. et al. An oral antisense oligonucleotide for PCSK9 inhibition. Sci. Transl. Med. 13, eabe9117 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robson, A. Three different therapies to target PCSK9. Nat Rev Cardiol 18, 541 (2021). https://doi.org/10.1038/s41569-021-00581-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-021-00581-w
- Springer Nature Limited
This article is cited by
-
Branched chemically modified poly(A) tails enhance the translation capacity of mRNA
Nature Biotechnology (2024)